101 related articles for article (PubMed ID: 15671560)
1. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
Lev DC; Kim SJ; Onn A; Stone V; Nam DH; Yazici S; Fidler IJ; Price JE
Clin Cancer Res; 2005 Jan; 11(1):306-14. PubMed ID: 15671560
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous inhibition of EGFR, VEGFR, and platelet-derived growth factor receptor signaling combined with gemcitabine produces therapy of human pancreatic carcinoma and prolongs survival in an orthotopic nude mouse model.
Yokoi K; Sasaki T; Bucana CD; Fan D; Baker CH; Kitadai Y; Kuwai T; Abbruzzese JL; Fidler IJ
Cancer Res; 2005 Nov; 65(22):10371-80. PubMed ID: 16288027
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes.
Kadivar A; Kamalidehghan B; Akbari Javar H; Karimi B; Sedghi R; Noordin MI
Drug Des Devel Ther; 2017; 11():469-481. PubMed ID: 28260860
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
Boucharaba A; Serre CM; Grès S; Saulnier-Blache JS; Bordet JC; Guglielmi J; Clézardin P; Peyruchaud O
J Clin Invest; 2004 Dec; 114(12):1714-25. PubMed ID: 15599396
[TBL] [Abstract][Full Text] [Related]
5. A differential role for CD248 (Endosialin) in PDGF-mediated skeletal muscle angiogenesis.
Naylor AJ; McGettrick HM; Maynard WD; May P; Barone F; Croft AP; Egginton S; Buckley CD
PLoS One; 2014; 9(9):e107146. PubMed ID: 25243742
[TBL] [Abstract][Full Text] [Related]
6. Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas.
Baker CH; Kedar D; McCarty MF; Tsan R; Weber KL; Bucana CD; Fidler IJ
Am J Pathol; 2002 Sep; 161(3):929-38. PubMed ID: 12213721
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity.
Kim Y; Kim E; Wu Q; Guryanova O; Hitomi M; Lathia JD; Serwanski D; Sloan AE; Weil RJ; Lee J; Nishiyama A; Bao S; Hjelmeland AB; Rich JN
Genes Dev; 2012 Jun; 26(11):1247-62. PubMed ID: 22661233
[TBL] [Abstract][Full Text] [Related]
8. The Beta2-adrenergic agonist salbutamol synergizes with paclitaxel on cell proliferation and tumor growth in triple negative breast cancer models.
Jabloñski M; Rodríguez MS; Rivero EM; Bruque CD; Vanzulli S; Bruzzone A; Pérez Piñero C; Lüthy IA
Cancer Chemother Pharmacol; 2023 Dec; 92(6):485-499. PubMed ID: 37725114
[TBL] [Abstract][Full Text] [Related]
9. Detection of Treatment Response in Triple-Negative Breast Tumors to Paclitaxel Using MRI Cell Size Imaging.
Jiang X; McKinley ET; Xie J; Gore JC; Xu J
J Magn Reson Imaging; 2024 Feb; 59(2):575-584. PubMed ID: 37218596
[TBL] [Abstract][Full Text] [Related]
10. The relationships of platelet-derived growth factor, microvascular proliferation, and tumor cell proliferation in canine high-grade oligodendrogliomas: Immunohistochemistry of 45 tumors and an AFOB-01 xenograft mouse model.
Yoshida K; Chambers JK; Uchida K
Vet Pathol; 2024 Apr; ():3009858241241793. PubMed ID: 38577818
[TBL] [Abstract][Full Text] [Related]
11. VEGF165b Mutant Promotes the Apoptosis of Murine Breast Cancer Cells Induced by Paclitaxel by Inducing Tumor Vessel Maturation.
Liang C; Li Y; Guo E; Bai S; Wang Y; Zhang H
Protein Pept Lett; 2023; 30(11):951-958. PubMed ID: 37861033
[TBL] [Abstract][Full Text] [Related]
12. Role of Platelet-Derived Growth Factor-mediated signaling in carcinogenesis and metastasis.
Farooqi AA; Attar R
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):300-302. PubMed ID: 38279414
[TBL] [Abstract][Full Text] [Related]
13. Platelets govern pre-metastatic tumor communication to bone.
Kerr BA; McCabe NP; Feng W; Byzova TV
Oncogene; 2013 Sep; 32(36):4319-24. PubMed ID: 23069656
[TBL] [Abstract][Full Text] [Related]
14. Targeting endothelial PDGFR-β facilitates angiogenesis-associated bone formation through the PAK1/NICD axis.
Lin H; Lin R; Hou J; Zhu C; Liu G; Lin Y; Su J; Yang M; Yang B; Ma Y; Cheng C; Deng M; Yu B; Xu T; Wu H; Cui Z
J Cell Physiol; 2024 May; ():. PubMed ID: 38721633
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous fusion between cancer cells and endothelial cells.
Mortensen K; Lichtenberg J; Thomsen PD; Larsson LI
Cell Mol Life Sci; 2004 Aug; 61(16):2125-31. PubMed ID: 15316661
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with anticancer vaccine using genetically modified endothelial cells and imatinib in bladder cancer.
Ha SB; Park YH; Lee E; Ku JH; Kim HH; Kwak C
Korean J Urol; 2011 May; 52(5):327-34. PubMed ID: 21687392
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum to "Xiao-Ai-Ping Injection Enhances Effect of Paclitaxel to Suppress Breast Cancer Proliferation and Metastasis via Activating Transcription Factor 3".
Integr Cancer Ther; 2023; 22():15347354231221271. PubMed ID: 38130179
[No Abstract] [Full Text] [Related]
18. Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cells.
Thouverey C; Apostolides P; Brun J; Caverzasio J; Ferrari S
JCI Insight; 2024 May; 9(10):. PubMed ID: 38713511
[TBL] [Abstract][Full Text] [Related]
19. Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation.
Nätkin R; Pennanen P; Syvälä H; Bläuer M; Kesseli J; Tammela TLJ; Nykter M; Murtola TJ
PLoS One; 2023; 18(2):e0281645. PubMed ID: 36809527
[TBL] [Abstract][Full Text] [Related]
20. The Signaling Pathways Associated With Breast Cancer Bone Metastasis.
Song X; Wei C; Li X
Front Oncol; 2022; 12():855609. PubMed ID: 35372035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
